Advertisement Roxane Laboratories launches protriptyline HCl tablets, USP - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roxane Laboratories launches protriptyline HCl tablets, USP

Roxane Laboratories, a subsidiary of Boehringer Ingelheim, has announced the approval of its abbreviated new drug application for protriptyline HCl tablets, USP, 5mg and 10mg.

The product is available in bottles of 100 tablets for immediate shipment to wholesalers and pharmacies nationwide.

Roxane Laboratories’s protriptyline HCl tablets, USP are AB rated to Vivactil (protriptyline HCl).